MedTrace Logo

Quality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM)

NCT03518814 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2018-07-19

No results posted yet for this study

Summary

Few studies have been conducted on the quality of life of patients with stage IV melanoma. Particularly, there is no data regarding the quality of life of patients with a multimetastatic melanoma currently in remission.

Then, the main objective of this study is to evaluate the quality of life from a point of view medico-psycho-social in patients with multimetastatic melanoma in remission for more than 6 months.

Conditions

  • Melanoma (Skin) Stage IV
  • Remission

Interventions

OTHER

Questionnaires

FACT-M (Functional Assessment of Cancer Therapy - Melanoma) questionnaire, MOS SF (medical outcome study short form) -36 questionnaire

Sponsors & Collaborators

  • University Hospital, Lille

    collaborator OTHER

  • Lille Catholic University

    lead OTHER

Principal Investigators

  • Aurore Le Guern · Lille Catholic University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-09
Primary Completion
2018-06-05
Completion
2018-06-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03518814 on ClinicalTrials.gov